Neurogene Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.

About NGNE

Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.

CEO

Rachel L. McMinn

CEORachel L. McMinn

Employees

107

Employees107

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2007

Founded2007

Employees

107

Employees107

NGNE Key Statistics

Market cap

280.82M

Market cap280.82M

Price-Earnings ratio

-4.22

Price-Earnings ratio-4.22

Dividend yield

—

Dividend yield—

Average volume

308.48K

Average volume308.48K

High today

$21.19

High today$21.19

Low today

$19.04

Low today$19.04

Open price

$19.29

Open price$19.29

Volume

237.77K

Volume237.77K

52 Week high

$74.49

52 Week high$74.49

52 Week low

$6.88

52 Week low$6.88

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own NGNE. This list is generated using Robinhood data, and it’s not a recommendation.